Recent articles analyzed the risks of migraines, age-related macular degeneration, and loss of skeletal muscle mass in patients taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs) after age 65 years.
ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.
Recent articles analyzed the risks of migraines, age-related macular degeneration, and loss of skeletal muscle mass in patients taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs)…
This month’s quiz asks readers to evaluate a 64-year-old man who has recurrent hypoglycemia that occurs three to four times per week. He takes metformin,…
Kidney cancer risk was significantly higher in patients with prolonged duration of diabetes, those with diabetic retinopathy or nephropathy, and those with poor glycemic control,…
Patients with type 2 diabetes and chronic kidney disease (CKD) had a greater reduction in urinary albumin-to-creatinine ratio if they took finerenone plus empagliflozin versus…
A two-tier system for stratifying patients based on their risk of metabolic dysfunction-associated steatotic liver disease (MASLD) was recommended by the American Diabetes Association (ADA).
Sexual dysfunction can be as routine a part of primary care as diabetes or cardiovascular disease, one expert says.
Internal medicine shares globally many of the same issues that affect it domestically, demanding an internationally coordinated response.
I.M. Matters Weekly from ACP’s cartoon caption contest continues. Readers can vote for their favorite caption to determine the winner.
In an article on KevinMD, Janet Jokela, MD, MPH, MACP, recalls her own experience seeing a suspected measles case and encourages physicians to stay vigilant.
